GGrantIndex
← Leaderboards

Jia Zhu

University Of Washington

$9,917,023
Attributed
$11,004,262
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,004,262 · 7

By mechanism

R01$8,316,717 · 4
P01$1,326,615 · 1
U18$1,043,397 · 1
R56$317,533 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Lesion

Research focus

LesionVaccinesImmuneCellsSkinTissuesViralHuman Herpesvirus 2InfectionMucous MembraneImmune ResponseT-LymphocyteImmunityContainmentCd8b1 GeneImmunologic SurveillanceUlcerVirusSimplexvirusChemokineResponseBiopsyGenital HerpesPathogen

Grant awards (25)

Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence$862,878
R01 · FY2025 · AI · contact PI
Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence$881,878
R01 · FY2024 · AI · contact PI
Modeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusion$524,841
R01 · FY2024 · AI · contact PI
Modeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusion$533,495
R01 · FY2023 · AI · contact PI
Modeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusion$533,495
R01 · FY2022 · AI · contact PI
Modeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusion$535,611
R01 · FY2021 · AI · contact PI
Biofabricated 3-D skin model for antiviral drug discovery against human HSV infection$517,861
U18 · FY2021 · TR · contact PI
Modeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusion$542,410
R01 · FY2020 · AI · contact PI
Biofabricated 3-D skin model for antiviral drug discovery against human HSV infection$525,536
U18 · FY2020 · TR · contact PI
Mechanisms of Protective Local Immunity in Human Female Reproductive Tract$315,885
R01 · FY2018 · AI · contact PI
Mechanisms of Protective Local Immunity in Human Female Reproductive Tract$315,885
R01 · FY2017 · AI · contact PI
Correlating HSV-2 Disease Severity with Tissue Resident CD8 T-cells$248,392
P01 · FY2017 · AI · contact PI
Mechanisms of Protective Local Immunity in Human Female Reproductive Tract$457,589
R01 · FY2016 · AI · contact PI
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons$437,105
R01 · FY2016 · AI
Correlating HSV-2 Disease Severity with Tissue Resident CD8 T-cells$285,580
P01 · FY2016 · AI · contact PI
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons$437,133
R01 · FY2015 · AI
Mechanisms of Protective Local Immunity in Human Female Reproductive Tract$317,320
R01 · FY2015 · AI · contact PI
Correlating HSV-2 Disease Severity with Tissue Resident CD8 T-cells$271,947
P01 · FY2015 · AI · contact PI
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons$437,156
R01 · FY2014 · AI
Mechanisms of Protective Local Immunity in Human Female Reproductive Tract$320,951
R01 · FY2014 · AI · contact PI
Correlating HSV-2 Disease Severity with Tissue Resident CD8 T-cells$244,115
P01 · FY2014 · AI · contact PI
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons$409,622
R01 · FY2013 · AI
Correlating HSV-2 Disease Severity with Tissue Resident CD8 T-cells$276,581
P01 · FY2013 · AI · contact PI
Cytotoxic T-Cell Responses to HSV in HIV-Infected Persons$453,463
R01 · FY2012 · AI
Mechanisms of CD8+ T cell Immune surveillance in human genital skin and mucosa af$317,533
R56 · FY2012 · AI · contact PI